Some visit links earn us a commission.

Lowest compounded tirzepatide drug price in Utah 2026: $69 a month, plus yearly membership

By John Samaras, price analyst · Prices checked Nov 16, 2026

Compounded tirzepatide, a pharmacy-made version that is not Zepbound or Mounjaro, ships to Utah from $69 a month at Collective, plus a yearly membership, the lowest of the programs we track, read on November 16, 2026. Utah Medicaid does not cover Zepbound for weight loss.

Paying cash for compounded tirzepatide in Utah

Eden logo

Weight loss or money back Eden

compounded tirzepatide
$129/mo

Includes medication, provider review and shipping

Ships to Utah. Same price at every dose.

Collective logo

Lowest monthly drug price Collective

compounded tirzepatide
$69/mo

Ships to Utah. Same price at every dose.

Some links earn us a commission.

Who ships compounded tirzepatide to Utah

  1. Collective: $69 a month
  2. Eden: $129 a month
  3. CoreAge Rx: $129 a month
  4. Embody: $129 a month
  5. SnagRx: $149 a month

Every program on our compounded tirzepatide chart ships to Utah. The full chart has every price.

Does Utah Medicaid cover Zepbound?

Utah Medicaid does not cover Zepbound for weight loss. It does cover Zepbound for obstructive sleep apnea, with prior authorization. Utah Medicaid plans include Healthy U (University of Utah Health Plans), Molina Healthcare of Utah, SelectHealth Community Care and Health Choice Utah.

Utah Medicaid stopped covering GLP-1s for weight loss on June 30, 2026. A one-year pilot ran July 1, 2025 through June 30, 2026, funded by an appropriation rather than standing law, and it was not renewed. It also only ever applied to fee-for-service members, so anyone in a managed-care plan (Molina, SelectHealth, Healthy U, Health Choice) never had it. Utah's prior-authorization form was renamed 'GLP-1 Medications for Weight-related Comorbidities' on June 1, 2026 and the obesity approval criteria were removed, so there is no approval path left. Other uses continue: type 2 diabetes, heart-attack and stroke risk reduction (Wegovy injection or pill, BMI 27 or higher with a prior heart attack, stroke or symptomatic peripheral artery disease, and you must already be on prevention therapy), sleep apnea (Zepbound, BMI 30 or higher with an AHI of 15 or higher) and MASH, a fatty liver disease (Wegovy injection, fibrosis F2 to F3).

The Utah Medicaid drug list was last reviewed July 1, 2026. Utah Medicaid GLP-1 rules.

GLP-1 prescriptions Utah Medicaid paid for

QuarterPrescriptionsMedicaid paidPer prescription
Apr to Jun 20254,597$4.8 million$1,050
Jul to Sep 20254,812$5.0 million$1,050
Oct to Dec 20255,350$5.6 million$1,040
Jan to Mar 20265,633$5.7 million$1,020

Utah Medicaid paid for 5,633 GLP-1 prescriptions in the first quarter of 2026, up 23% from 4,597 in the second quarter of 2025.

Source: CMS State Drug Utilization Data, all GLP-1 brands, before rebates.

Obesity and insurance in Utah

29.8% of adults in Utah had obesity in 2025, by the CDC's state survey, against 33.5% for the US as a whole. 10.5% of Utah residents have no health insurance and 9.0% live below the poverty line (Census SAIPE 2023). Of the largest counties, Tooele County has the highest adult obesity rate, 37.6% (CDC PLACES 2025).

CountyAdults with obesityNo health insuranceBelow the poverty line
Salt Lake County29.9%11.6%9.5%
Utah County29.7%9.6%9.0%
Weber County34.7%11.3%8.5%
Washington County33.1%10.0%10.6%
Davis County32.7%8.8%6.0%
Cache County27.9%9.7%10.7%
Iron County35.3%10.0%11.6%
Tooele County37.6%10.7%6.8%
Box Elder County32.6%10.3%8.5%
Uintah County35.5%11.3%11.1%

Source: CDC PLACES 2025 for obesity, Census SAIPE 2023 for insurance and poverty.

More for Utah

Compounded tirzepatide is made by a licensed pharmacy to a prescription and is not FDA-approved. A prescriber decides whether it suits you.